Skip to main content
. 2022 Jun 6;40(25):2878–2888. doi: 10.1200/JCO.22.00839

FIG 1.

FIG 1.

CONSORT diagram. aPatients included in the intention-to-treat population. bPatients included in the safety population. FOLFOX, fluorouracil, leucovorin, and oxaliplatin; mFOLFOXIRI, modified fluorouracil, leucovorin, oxaliplatin, and irinotecan.